When was Autonomize founded?

Autonomize was founded in 2021 and raised its 1st funding round 2 years after it was founded.

Where is Autonomize located?

Autonomize is headquartered in Austin, United States.

How many employees does Autonomize have?

As of Jun 30, 2026, the latest employee count at Autonomize is 158.

Is Autonomize a funded company?

Autonomize is a funded company, having raised a total of $32M across 2 funding rounds to date. The company's 1st funding round was a $***** Seed round, raised on Apr 10, 2023.

When was the latest funding round of Autonomize?

Autonomize's latest funding was a $***** Series A round on May 28, 2025, with participation from 6 investors.

Where does Autonomize rank among its competitors?

Autonomize ranks 15th amongst 304 active competitors, of which 55 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Verily, which secured $300M in Mar, 2026.

Who are the top competitors of Autonomize?

Autonomize's top competitors include Medidata, Verily and IQVIA. Among them, Verily secured the most recent funding round in March, 2026.

Autonomize - 2026 Company Profile, Team, Funding & Competitors

Autonomize is a series A company based in Austin (United States), founded in 2021 by Ganesh Padmanabhan and Kris Nair. It operates as an AI-based drug discovery tool for researchers. Autonomize has raised $32M in funding from investors like Asset Management Ventures, Tau Ventures and Cigna Ventures. The company has 304 active competitors, including 55 funded and 42 that have exited. Its top competitors include companies like Medidata, Verily and IQVIA.

Company Details

AI-based drug discovery tool for researchers. The company has developed software that assists with drug targeting and clinical trial management. It has features for drug toxicity, clinical and biomedical data, workflow management, and more.

Website: autonomize.ai
Social
Email ID: *****@autonomize.ai

Key Metrics

Founded Year

2021

Location

Austin, United States

Stage

Series A

Total Funding

$32M in 2 rounds

Latest Funding Round

Series A, May 28, 2025, $*****

Investors

Asset Management Ventures & 9 more

Ranked

15^th among 304 active competitors

Employee Count

158 as on Jun 30, 2026

Similar Companies

Medidata & 347 more

View Autonomize's full profile

Autonomize is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
JLL CAPITAL GROUP INC. CIN: 6226987 , United States, Active	Jul 23, 2021	-	-	-
AUTONOMIZE, INC. CIN: 32088496297 , United States, Active	Feb 17, 2023	-	-	-

Autonomize has raised a total funding of $32M over 2 rounds. Its first funding round was on Apr 10, 2023. Its latest funding round was a Series A round on May 28, 2025 for $*****. 6 investors participated in its latest round. Autonomize has 9 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Autonomize:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 28, 2025	8820407	Series A	3701758	1594442	2444853	4197534
Apr 10, 2023	4677474	Seed	9060667	9819771	Asset Management Ventures	ATX Venture Partners & 2 more

Access funding benchmarks and valuations. Sign up today!

View details of Autonomize's funding rounds and investors

The founders of Autonomize are Ganesh Padmanabhan and Kris Nair.

Here are the details of Autonomize's key team members:

Ganesh Padmanabhan: Co-Founder of Autonomize.
Kris Nair: Co-Founder of Autonomize.
Contact Info: 1 email address

View details of Autonomize's Founder profiles and Board Members

Autonomize's employee count trend

Autonomize has 158 employees as of Jun 26. Here is Autonomize's employee count trend over the years:

Uncover Autonomize's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Autonomize include Medidata, Verily and IQVIA. Here is the list of Top 10 competitors of Autonomize, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Medidata 1999, New York City (United States), Acquired	AI-based clinical trial management software for researchers	$41.5M	Insight Partners, TFS & 11 others	86/100
2nd	Verily 2015, Dallas (United States), Series D	A data platform and technology company purpose-built to power AI-enabled precision health	$2.8B	Silver Lake, Temasek & 9 others	82/100
3rd	IQVIA 1982, Durham (United States), Public	Provider of clinical research and commercialization solutions for healthcare	$1.74M	Leonard Green and Partners, Morgan Stanley ... & 12 others	80/100
4th	Tempus 2015, Chicago (United States), Public	Developer of genomic testing and artificial intelligence tools for medicine	$1.05B	New Enterprise Associates, T. Rowe Price ... & 11 others	78/100
5th	Signant Health 2000, Plymouth Meeting (United States), Acquired	Provider of a software solution for clinical trial management	$3.4M	Harvest Partners, 3i Group & 4 others	72/100
6th	Science 37 2014, Los Angeles (United States), Acquired	Provider of a suite solution for clinical trials for researchers	$106M	Redmile Group, Lux Capital & 12 others	70/100
7th	Viz.ai 2016, San Francisco (United States), Series D	Developer of an AI-powered platform for care coordination and disease detection	$252M	Insight Partners, Tiger Global Management ... & 16 others	70/100
8th	Massive Bio 2014, New York City (United States), Series B	Provider of AI-based clinical trial management tool	$15.6M	Revo Capital, Philips HealthWorks & 8 others	66/100
9th	TriNetX 2013, Cambridge (United States), Acquired	Provider of clinical trial management software for researchers and professionals	$102M	Merck Global Health Innovation Fund, MPM Capital ... & 6 others	66/100
10th	BrightInsight 2017, San Jose (United States), Series C	Provider of digital health solutions for clinical trials	$179M	Insight Partners, General Catalyst & 8 others	64/100
15th	Autonomize 2021, Austin (United States), Series A	AI-based drug discovery tool for researchers	$32M	Cigna Ventures, ATX Venture Partners & 8 others	61/100